Atlantic Coastal Acquisition Corp. II Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q NEW YORK, June 13, 2024 /PRNewswire/ -- Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB) (the "Company"), a special purpose acquisition company, announced that it had previously received written notification (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock…
Atlantic Coastal Corp. II Advances Abpro Merger Plans Atlantic Coastal Acquisition Corp. II Class A (ACAB) has shared an announcement. Atlantic Coastal Acquisition Corp. II has announced an amendment t…
Biotechnology company Abpro to merge with SPAC Atlantic Coastal Acquisition Biotech company Abpro is set to merge with Atlantic Coastal Acquisition Corp. II. The transaction aims to accelerate Abpro''s pipeline and development of immunotherapies.